Inbija’s “Now Approved” Pages for Patients and HCPs




Brand: Inbrija (levodopa), Inhalation Powder
Parent Company: Acorda Therapeutics
Drug Type: Prescription
Drug Category: Neurology
Campaign: now-approved
Targeting: HCPs, Patients, Caregivers
Patient Website: https://www.inbrija.com/
HCP Website: https://www.inbrija-hcp.com/